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Lett. 31, L01107 (2004 Sequencing of exomes and genomes has revealed abundant genetic variation affecting the coding sequences of human transcription factors (TFs), but the consequences of such variation remain largely unexplored. We developed a computational, structure-based approach to evaluate TF variants for their impact on DNA binding activity and used universal protein-binding microarrays to assay sequence-specific DNA binding activity across 41 reference and 117 variant alleles found in individuals of diverse ancestries and families with Mendelian diseases. We found 77 variants in 28 genes that affect DNA binding affinity or specificity and identified thousands of rare alleles likely to alter the DNA binding activity of human sequence-specific TFs. Our results suggest that most individuals have unique repertoires of TF DNA binding activities, which may contribute to phenotypic variation.
E
xome sequencing studies have identified many nonsynonymous single-nucleotide polymorphisms (nsSNPs) in transcription factors (TFs) (1) . Genetic variants that alter transcript expression levels have been associated with human disease risk and are widespread in human populations (2, 3) . Numerous Mendelian diseases are attributable to mutations in TFs (4) . Missense SNPs that change the amino acid sequence of TF DNA binding domains (DBDs) might disrupt their DNA binding activities and thus have detrimental effects on their gene regulatory functions. Despite their medical importance, the consequences of coding variation in DBDs for TF function have remained largely unexplored.
We identified 53,384 unique DBD polymorphisms (DBDPs) (table S1) (here, defined as missense variants) in a curated, high-confidence set of 1254 sequence-specific human TFs (5, 6) (table S2) from genotype data for 64,706 individuals encompassing African, Asian, and European ancestries (Fig. 1A) (1, 2, 7) . We also identified 4552 unique nonsense mutations that result in partial or full DBD truncation (table S3) .
We found a median of 60 heterozygous and 20 homozygous DBDPs (Fig. 1B) per genome. We found a significant depletion (odds ratio = 3.7, P = 0.005, Fisher's exact test) of DBDPs among TFs with known Mendelian disease mutations (6, 8) , suggesting that DBDPs in disease-associated TFs have phenotypic consequences.
We developed a computational approach (6) to evaluate missense substitutions in TF DBDs for their impact on DNA binding activity. Existing methods for predicting the impact of missense mutations (9, 10) do not adequately consider the roles of residues in protein-DNA interactions, which we reasoned should improve predictions. We first focused on homeodomain DBDs, as most known Mendelian disease mutations in TFs occur in homeodomain proteins. We analyzed homeodomain-DNA cocrystal structures in the Protein Data Bank to assemble a composite protein-DNA "contact map" (fig. S1 ). As anticipated, residues that contact DNA bases or phosphate backbone, or that immediately neighbor base-contacting residues, are enriched among Mendelian disease mutations (P < 0.005, permutation test). In contrast, individuals in the population are depleted for variants at base-or backbone-contacting positions (P = 0.0134 or 0.0312, respectively, permutation test) (Fig. 1C) . This highlights the value of considering protein-DNA contacts in predicting the impact of variants.
On the basis of these results, we expanded our approach to other TF families. , Wilcoxon rank-sum test), resulting in E-scores indistinguishable from GST negative controls (table S7) . (D) Fraction of alleles with observed changes in DNA binding affinity, specificity, both, or neither as determined from PBM binding profiles. Prioritized nsSNPs exclude those predicted as benign by both PolyPhen-2 and SIFT. (E) Violin plots depicting fraction of 8-mer binding sites gained or lost by variants relative to the number of 8-mers bound by the reference allele. Gains or losses were defined as E ≥ 0.4 for one allele and E < 0.4 for the other allele. *P = 0.0044, Wilcoxon rank-sum test. S1); (ii) DNA binding specificity-determining residues for particular DBD classes (fig. S2) ; (iii) scores from tools that predict mutation pathogenicity (9, 10); (iv) minor allele frequencies; and (v) phenotypic associations from genome-wide association studies (11) or known Mendelian disease mutations (8) .
Using these criteria, we selected 37 TF DBDPs (6) to assay for direct, sequence-specific DNA binding activity ( fig. S3 ). These DBDPs were obtained from the 1000 Genomes Project (1kG) Phase 2, the Exome Sequencing Project (ESP 6500), and the Exome Aggregation Consortium (ExAC). To calibrate the effects of these nsSNPs, we selected 80 Mendelian disease mutations, which are known or believed to be pathogenic (Fig. 1D) (8, 12) . The 117 variant DBD alleles span six major structural classes, representing 41 distinct TF allelic series ( fig. S4 ). We assayed these 158 DBD alleles using universal protein-binding microarrays (PBMs) (6), on which each nonpalindromic 8-base pair sequence (8-mer) occurs on at least 32 spots (13) (table S4) .
We identified variant-induced changes in DNA binding specificity (14) (Fig. 2A) or affinity (Fig.  2B ) by comparing the enrichment (E) scores of each of 32,768 nonredundant, ungapped 8-mers represented on universal PBMs to those of the corresponding reference allele (6, 13). DNA binding changes were reproducible across replicate PBM experiments and support previously reported DNA binding affinity differences (table S5 and fig. S5 ). We categorized all 117 variant alleles as having altered DNA binding specificity, affinity, both, or neither (table S6) . Three nsSNPs completely abrogated sequence-specific DNA binding (Fig. 2C  and fig. S6 ). In total, 77 variants altered DNA binding affinity and/or specificity (Fig. 2D) . Several nsSNPs predicted to be damaging but not scored here as having altered DNA binding might cause subtle changes beyond the sensitivity of our approach or alternatively affect protein-protein interactions.
Compared to DBDPs, Mendelian disease mutants lost a larger fraction of 8-mers bound by the corresponding reference alleles (P = 0.0044, Wilcoxon rank-sum test), consistent with more extreme phenotypes being associated with more drastic in vitro binding changes. The overall difference in gained 8-mers was not significantly different between these two sets of variants (P = 0.32, Wilcoxon rank-sum test; Fig. 2E ).
PBM binding profiles within an allelic series differed for variants associated with distinct disease phenotypes ( fig. S7) , supporting results from a yeast one-hybrid screen of Mendelian disease TF mutants (15) . They also provided molecular insights into the molecular basis of clinical heterogeneity of disease mutations affecting the same genes. For example, CRX is associated with Mendelian diseases of retinal degeneration (16) . The R90W allele, associated with the severe disease Leber congenital amaurosis 7 (17), lost the ability to bind most 8-mers bound by wild-type CRX. In contrast, the R41W allele, associated with conerod dystrophy 2 (18), resulted in a moderate specificity change (fig. S7B) .
The 8-mer binding profiles of HOXD13 alleles displayed a range of effects; several of these alleles are associated with various limb malformations (19) (Fig. 3A) . The I297V and N298S variants, predicted to be benign, did not alter DNA binding activity. The Q325K and Q325R alleles gained recognition of novel motifs, consistent with those learned from chromatin immunoprecipitation with high-throughput sequencing (ChIP-Seq) data (12) . Allele-preferred 8-mers (Fig. 3B and fig. S8A ) are enriched within ChIP-Seq peaks bound exclusively by the respective allele (Fig. 3C and figs. S8B and S9) (P < 0.01, Wilcoxon signed-rank test). Putative target genes, associated with ChIP-Seq peaks enriched (P < 2.2 × 10 −16
, one-tailed Wilcoxon signedrank test) for Q325K-or Q325R-preferred versus reference-preferred 8-mers ( fig. S10) (6) , are overrepresented among genes up-regulated by the corresponding allele (P < 0.01, permutation test) (Fig. 3D and figs. S8C and S11), consistent with HOXD13 acting as a transcriptional activator (20) . These results suggest that these variants' changes in binding specificity alter genomic occupancy, leading to inappropriate gene expression through gained binding sites. As expected, mutations in residues that either contact DNA or neighbor a base-contacting residue were enriched (odds ratio = 4.3, P = 0.003, Fisher's exact test) among DBDPs with altered DNA binding affinity or specificity (Fig. 4A) . We also found variants at non-DNA-contacting positions that altered DNA binding, potentially by affecting protein conformation or stability. We identified 3833 unique missense variants that are predicted to be damaging by both PolyPhen-2 (9) and SIFT (10) and occur at DNA-contacting residues (Fig. 4B) . These values are likely an underestimate of damaging DBDPs across all human TFs (Fig. 4C) . These damaging nsSNPs occur at lower frequencies in the ExAC population than do nsSNPs for which no change in DNA binding is predicted (P < 0.05, permutation test) (Fig.  4D) , suggesting that they are more likely to be deleterious.
Per individual, there were very few (median = 2) nonsense DBD variants but a wide range in the number of putatively damaging missense variants (median = 9, DBDPs at DNA-contacting residues and predicted as damaging by PolyPhen-2 and SIFT) (Fig. 4E and fig. S12 ). Hence, we investigated what mechanisms might allow damaged DBDPs to be tolerated. TFs reported to tolerate homozygous loss-of-function (LoF) mutations in Icelanders (21) had a significantly higher fraction of DNA-contacting residues altered by our identified nsSNPs (P = 6.63 × 10
, permutation test) (Fig. 4F) . TFs with a coexpressed paralog (22) had a significantly higher fraction of variable DNAcontacting residues (P = 6.11 × 10
, permutation test) (Fig. 4G) ; this enrichment was significant independent of LoF-tolerance status (P < 0.005, t test) (6) . Additional compensation could arise from epistasis with cis-regulatory variants (23) . Damaged DBDPs might be associated with undiagnosed or subclinical phenotypes, variably penetrant phenotypes due to epistatic or geneenvironment interactions, or phenotypes that present in later life.
Our results highlight the utility of PBM profiling to reveal changes in the DNA binding activities of variant DBDs. PBM profiling of DBDPs identified through additional sequencing studies may elucidate disease pathologies by revealing alterations in DNA binding that result in transcriptional dysregulation.
Our analyses suggest that most unrelated individuals have a unique repertoire of TF alleles with a distinct landscape of DNA binding activities. Variants with subtle changes in DNA binding activities may confer reduced deleteriousness and thus have greater potential for giving rise to phenotypic variation. Analysis of genetic interactions among TFs, TF variants, and noncoding regulatory variation likely will provide insights into the structure of genetic variation that leads to phenotypic differences among people. 
